Z22.7 Latent tuberculosis

Name of the Condition

• Latent tuberculosis

Summary

This code identifies individuals with latent tuberculosis infection (LTBI), where the Mycobacterium tuberculosis bacteria are present but inactive, causing no symptoms or disease. LTBI is not contagious, but the bacteria can reactivate later, leading to active tuberculosis (TB) disease. The designation supports screening, preventive treatment, and monitoring to reduce reactivation risk.

Causes

Latent tuberculosis infection occurs when the immune system controls Mycobacterium tuberculosis after exposure, preventing active disease. The bacteria remain dormant in the body, typically in the lungs, without causing symptoms or spreading to others. Reactivation can occur if the immune system weakens.

Risk Factors

• Close contact with someone with active TB.
• Residence or travel to regions with high TB prevalence.
• Weakened immune system (e.g., HIV, immunosuppressive therapy).
• History of inadequately treated active TB.
• Certain medical conditions (e.g., diabetes, silicosis).

Symptoms

Not applicable; individuals with LTBI have no symptoms of TB disease. Some may experience mild, nonspecific signs like fatigue, but these are not specific to LTBI.

Diagnosis

Diagnosis involves tests to detect TB infection, such as a tuberculin skin test (TST) or interferon-gamma release assay (IGRA). Chest imaging (e.g., X-ray) may be used to rule out active disease, as LTBI does not show abnormalities.

Treatment Options

Preventive therapy with isoniazid, rifampin, or other regimens reduces reactivation risk. Treatment duration and choice depend on individual factors, including age, immune status, and drug resistance.

Prognosis and Follow-Up

Most individuals with LTBI never develop active TB. Regular monitoring is recommended, especially for those with risk factors. Follow-up may include repeat testing or imaging if symptoms of active TB emerge.

Complications

Reactivation of LTBI can lead to active TB, which is contagious and may cause serious illness (e.g., lung damage, organ involvement). Untreated LTBI carries a lifelong risk of reactivation.

Lifestyle & Prevention

• Avoid exposure to active TB cases.
• Complete preventive therapy as prescribed.
• Maintain a healthy immune system (e.g., balanced diet, regular exercise).
• Follow public health guidelines for TB screening in high-risk groups.

When to Seek Professional Help

Seek care if symptoms of active TB appear (e.g., persistent cough, fever, weight loss) or if exposure to active TB is suspected. Prompt evaluation is critical to prevent disease progression.

Tips for Medical Coders

Document the basis for LTBI diagnosis (e.g., positive TST/IGRA, exposure history) and any preventive treatment. Ensure coding aligns with clinical documentation, as LTBI is distinct from active TB.